This past weekend I attended a CE for medical directors, nursing home administrators and pharmacists. There was a lot of great information focused on taking care of the whole patient. The take-home message resounds in the Homerun Slides we have for you this week. These slides give you the basis …

I am a diabetes educator and certified foot care nurse. Through the years, I’ve learned that most topics we teach people who have diabetes are really topics every person should know about. I teach patients how to care for their feet, how to prevent foot problems, and how to treat them if they should have problems.

Dr. Yehuda Handelsman talks with Diabetes in Control Publisher Steve Freed at the 2016 AACE Meeting. In part 1 of this Exclusive Interview, Dr. Handelsman explains the necessity of a comprehensive approach when it comes to the physicians' management of diabetes.

In this week's Homerun Slides, understanding the behavior of insulin and other injectables to decrease incidences of hyperglycemia.

Vasoactive intestinal polypeptide (VIP): VIP was originally isolated from the porcine small intestine in the early 1970s and found to consist of 28 amino acid residues, with a C-terminal α-amidation showing structural similarities to other members of the glucagon superfamily of peptides [18]. VIP is formed by processing of 149-amino acid proVIP and is highly conserved as illustrated by human, porcine, and rat VIP increased glucose tolerance with a reduction of circulating glucose.

The standard treatment for uncontrolled uterine bleeding has been emergency care where a woman undergoes transfusion dilatation curettage and then a hysterectomy. This is a severe procedure with a long recovery time and long-lasting complications. Over the past few years, a lot of women have been treated with endometrialhydrothermal ablation, a much less invasive procedure with …

A1C reductions seen in therapy combined with metformin

Can glycated albumin provide better positive predictive value than A1c in incidence of diabetic nephropathy?

Canagliflozin can decrease blood sugar and provide control, but what other metabolic effects can it provide?

What benefits can be obtained from duodenal mucosal resurfacing?